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Abstract
Introduction: Due to advances in recent decades in maternal-
foetal and neonatal medicine, a greater survival of preterm 
infants with progressively smaller birth weight and gestational 
age is observed, increasing the risk of future morbidities on 
those infants. Among these morbidities, alterations in growth 
and metabolism are found. 
Objective: To analyze the evolution of the growth and the 
metabolic profile of preterm infants’ cohort from birth at six 
months of corrected age (CA). 
Methods: A descriptive and prospective study with a 
sample of 107 mothers and 115 preterm infants at birth 
and 72 preterm infants and 68 mothers at the end of follow-
up. Growth (body weight, height, cephalic perimeter) was 
evaluated at six time points. Plasma concentrations of 
cholesterol, triglycerides, glucose and insulin of premature 
infants were assessed during three periods, from birth to 6 
months of CA. Comparative analysis of the initial sample and 
the sample that finished the follow-up was used in chi-square 
family tests. To Evaluate the growth over the 6-month period 
by using repeated measurements. 
Results: Sociodemographic variables and maternal 
biochemical profile without statistical differences in the 
comparison of the mothers of the initial sample with those 
who completed the follow-up. Linear growth of preterm infants 
at six months of CA, however without recovery of growth. 
Plasma concentrations of triglycerides (birth = 48.1, 6 months 
= 151.1) and cholesterol (birth = 82.7, 6 months = 139.9) 
increased during the evaluations. Glycaemia remained stable 
(birth 80.4, 6 months = 83.3) and insulin decreased from 11.0 
to 4.2. 
Conclusion: Growth of preterm infants, although linear, 
was lower than expected for age. Lipid profiles presented an 
ascending curve from birth onward. Therefore, this group is 
prone to delayed growth and to developing cardiovascular 
changes throughout life.
Keywords: premature infant, growth, lipids, blood glicose, 
insulin.
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With the scientific and technological advances of 
recent decades, an increase in the survival of premature 
new-borns (PT) has been identified, each time with a 
lower gestational age (GA). Consequently, these PT 
remain for long periods in neonatal intensive care units 
(NICU). Despite the intensive care offered, these children 
are subject to complications due to prematurity and to the 
procedures and manipulations they undergo, both during 
hospitalization and after discharge from the NICU.  
Still associated with the adversities of the extra-
uterine environment, the foetal period is often experienced 
in a sub-optimal intrauterine environment, so PTs are 
subject to injuries throughout their lives1. Among them 
are those that affect growth, which is a continuous process 
resulting from the interaction of genetic, hormonal, 
environmental and nutritional factors2.
Intrauterine malnutrition and low birth weight 
associated with changes in growth in the first year of 
life predispose the individual to metabolic alterations 
in adulthood3. Changes in postnatal growth may 
lead to growth retardation4 and chronic problems in 
childhood, adolescence and adulthood5. In this context, 
the development of obesity, cardiovascular diseases, 
hypertension, diabetes mellitus type 2 (DM2) and 
dyslipidaemia are highlighted. All these diseases 
characterize the metabolic syndrome (MS), whose basis 
for all these alterations is resistance to insulin. This 
situation corroborates the current understanding that 
diseases in adulthood may be of foetal origin6. 
The phenomenon of early catch-up, that is, the 
acceleration in the PT growth rate, although beneficial 
to neurodevelopmental outcomes, is also related to 
adverse metabolic consequences in adulthood7. Premature 
infants are at a high risk of accelerated weight gain in the 
postnatal period leading to obesity later in life as well as 
the development of diseases linked to MS8. Studies show 
an increasing association between the risk of obesity 
and metabolic disease in adulthood, influenced by the 
intrauterine environment experienced in the foetal period 
and in the postpartum period9-11. 
Despite these lines of evidence, in Brazil, the 
continuity of health care for PT in the first years of life 
presents gaps in the literature regarding the repercussions 
of the PT growth rate and the evolution of the lipid and 
glycaemic profiles in the first weeks of life and in the long 
run. Knowing these aspects in this group is urgent: on 
one hand, there is a need to increase the weight of these 
children to reduce the nutritional deficit that causes greater 
morbidity and mortality in the first years of life and brings 
with it positive neurological repercussions; on the other 
hand, the accelerated weight gain is associated with risks 
of cardiovascular diseases and MS later in life12,13.
In this sense, the routine follow-up of PT after 
discharge from the NICU should include the monitoring 
of growth evolution combined with the analysis of the 
metabolic profile of these children in the corrected first 
year of age to identify the health risks of these PTs and to 
prevent the onset of obesity and its comorbidities in adult 
life.
Considering the scientific evidence about the PT 
growth rate and the health repercussions, and because 
the national literature presents few studies demonstrating 
the lipid and glycaemic parameters in prematurity, this 
study aims to characterize the evolution of growth and the 
metabolic profile of a PT cohort from birth to 6 months of 
corrected age (CA).
 INTRODUCTION
This was a prospective study, developed in a university 
hospital in Paraná, from June 2015 to December 2016. The 
study population consisted of mothers and their PT admitted 
to the NICU.
Participants who met the following inclusion criteria 
were included in the first stage of the study upon admission to 
the NICU: less than 37 weeks of GI, childbirth that occurred 
in the institution, absence of malformation and minimum of 7 
days’ stay in the NICU.
In the second stage, all those selected in the first stage 
who returned to the outpatient clinic were included, and four 
follow-up appointments were scheduled as follows: 7–10 
days, 1 month and 3 months after discharge from hospital and 
at 6 months of CA.
The mothers and PTs included in the study at the time 
of PT admission to the NICU were called the initial sample, 
and all those PTs and their mothers who attended the follow-
up visits at 6 months of CA were identified as the final sample. 
Thus, the study sample was obtained by convenience sampling, 
in which an initial sample was obtained, totalling 107 mothers 
and 115 PTs. The loss at follow-up was 37.39%; therefore, the 
final sample consisted of 72 PTs and their respective mothers 
(n = 68 due to twin births). For the evaluation of PT data, 
the chi-square family test with a sample power of 0.99 and a 
mean effect size of 0.25 was used. All statistical analyses were 
performed in the Statistica 7.0 program14.
For the evaluation of growth over the 6-month 
period, the 72 PTs were evaluated through six measures, 
corresponding to the admission period; discharge from the 
NICU; evaluation 1, 7–10 days after discharge; evaluation 
2, 1 month after discharge from the NICU; evaluation 3, in 
the third month after discharge and evaluation 4, at 6 months 
of corrected age. This sample was analysed by means of 
a repeated measures design and, for this, the effect size 
was 0.15, the probability of a type I error was 0.05 and the 
sampling power was 0.99.
Data collection was performed by a trained team of 
researchers who followed daily work schedules, collecting 
the maternal sociodemographic information and clinical 
data of the PTs through a previously tested instrument and 
feeding the database with double checking, updated daily.
The study participants’ enrolment began with the 
consent of the pregnant woman in preterm labour at the 
Obstetric Centre (OC). At the time of enrolment in the 
study, analysis of the glycaemic (glucose and insulin) 
and lipid (total and triglycerides) profiles was conducted 
from routine blood samples taken at routine admission 
examinations of pregnant women in the OC. 
 METHODS
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perimeter (CP), weight and height verified on admission 
to the NICU and weekly, following the standard operating 
procedure established for the unit. The anthropometric 
measurements at the time of discharge from the NICU 
were recorded.
Data analysis used the chi-square test for 
independent samples using the Monte Carlo permutation 
method for qualitative variables. The quantitative 
variables were evaluated by analysis of variance for 
repeated measures, followed by Fisher’s least significant 
difference test to verify the differences between the 
averages at each evaluation time point of the biochemical 
data, with a significance level of 5% (p = 0.05).
 RESULTS
Up to 72 hours after birth, a blood sample was 
obtained from the routine collection in the NICU 
to perform the biochemical analyses for glucose, 
triglycerides, total cholesterol and PT insulin. The 
maternal biochemical and PT assays were performed by 
the dry chemical method with a sensitivity of 10 mg/dL 
for triglycerides, 20 mg/dL for glycaemia and 50 mg/dL 
for total cholesterol. Insulin levels were measured using 
the electrochemiluminescence method with a sensitivity 
of 0.03 nIU/mL. The same analyses were performed 
on PT at the time of discharge from the NICU and at 
outpatient return at 6 months of CA. 
The anthropometric data collected were cephalic 
The maternal characterization showed no 
significant differences between the group of mothers in the 
initial sample (n = 107) and the final sample (n = 68) for 
maternal sociodemographic data (p > 0.05). The mothers 
had a mean age of 26 ± 7 years, with a minimum age of 
15 years and a maximum of 43 years. Regarding maternal 
biochemical parameters, a comparison of the biochemical 
profiles between the mothers who started and finished 
the follow-up did not produce a statistically significant 
difference (p > 0.05), with mean values of 102 ± 39 for 
glycaemia, 22 ± 34 for insulin, 201 ± 78 for triglycerides 
and 211 ± 48 for cholesterol.
Table 1: Sociodemographic characterization and morbidities of mothers from initial phase (n= 107) and mothers of the 
final phase of the research (n= 68). Cascavel, Paraná, Brazil, 2017.
Variable Categories n (107) (%) n (68****) (%) p value
Family income** <1 wage 4 4 3 4
0,713*
1 to 2 wage 55 51 36 53
3 to 4 wages 38 36 26 34
5 or more wages 7 7 6 9
Did not know 3 3 - -
Marital status Lives with the father of 
the PT
99 93     61   90
0,626*Single 7 6 7 10
Separated 1 1 - -
Occupation From home 48 45 27 40
0,935*
Formal employment 42 39 29 43
Informal employment 11 10 8 12
Others 6 6 4 6
Ethnicity Mixed 18 17 9 13
0,697*White 84 79 57 84
Black 5 5 2 3
Education Up to 4 years 7 6 4 6
0,855*
5 to 9 years 31 29 17 25
10 to 12 years 64 60 41 61
More than 12 years 5 5 5 7
Smoking No 94 88 62 91
0,491
Yes 13 12 6 9
Ethicism No 102 105 65 96
0,936
Yes 5 5 3 4
Pregnancy morbidity *** ITU 42 39 32 47
DHEG 32 30 19 28
0,816*
Gestational diabetes 4 4 2 3
Anaemia 5 5 2 3
Other conditions 38 36 32 47
* Chi-Square test for Independence using the Monte Carlo permutation method. ** National minimum wage during the survey was R $ 788.00 
in 2015 and R $ 880.00 in 2016. *** Some mothers had more than one morbidity. **** Total of 72 PT and 68 mothers due to twin births.
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Regarding PT, there was no statistically 
significant difference between the initial sample 
allocated at NICU admission and the one that 
completed the follow-up with respect to birth 
characteristics (Table 2), and the mean length of 
hospital stay was 24 days (minimum = 7 days, 
maximum = 93 days). The variables gender, birth 
weight, birth weight classification, Apgar score 
at 1 min and Apgar score at 5 min did not present 
statistically significant differences between the 
initial and final samples (p > 0.05). However, the 
highest frequency in the final sample occurred 
in those PTs with birth weight between 1000 and 
1499 g, which comprised 40% of occurrences.
Figure 1 shows the variables related to 
PT anthropometry that ended the follow-up at 6 
months of HF, as well as the Z score for each 
anthropometric variable from birth, hospital 
discharge and the four outpatient follow-up 
visits (n = 72).
The data presented in the graphs of 
PT longitudinal growth show a statistically 
significant (p < 0.0001) evolution in all 
variables (weight, CP and height) as a function 
of the moments evaluated [birth, discharge from 
hospital, first week and first and third month 
after hospital discharge and at 6 months of CA 
(Figure 1)].
Regarding Z scores, all variables presented 
a significant difference (p<0.0001).  However, 
there were moments of deceleration and 
stagnation of growth between one evaluation and 
the next one, denoting that growth recovery was 
lower than expected for the CA. The growth of 
these PTs showed decreases in mean Z-score in 
the period between birth and the first evaluation 
after discharge, recovering the growth between 
this period until the first month of CA however, 
between the third and sixth month of CA, with a 
slow progression of less than 0.67 SD between 
two consecutive Z scores.
Regarding the type of diet received by 
the 72 PTs who completed the follow-up, at 6 
months of HF, most of the sample (59.7%) was 
on infant formula, while 15.3% was on mixed 
breastfeeding, and 25% of the total PT sample 
was  exclusively breastfed. 
Table 3 shows the biochemical profile of 
PTs who comprised the final study sample (n= 72), 
describing glycemia, insulinaemia, total plasma 
cholesterol and triglyceride concentrations.
The PT blood glucose from admission to 
the NICU until 6 months of CA remained stable 
and was not statistically significant (p = 0.838). 
However, plasma concentrations of triglycerides 
and cholesterol were significantly different (p 
<0.0001) with a gradual increase during this 
period, whereas insulinaemia decreased during 
the same evaluation period     (p = 0.024).
Table 2: Characterization of the PT from the initial (n= 115) and final sample (n= 72). Cascavel, Paraná, Brazil, 2017.
Variable\Statistic Categories n (115) (%) n (72) (%) p value
Gender Female 48 42 32 44
0.716
Male 67 58 40 56
Gestational age <28 weeks 13 11 5 7
0,33628-31 weeks 27 23 23 32
32-36 weeks 75 65 44 61
Weight Birth <1000g 16 14 8 11
0,426
1000-1499g 33 29 29 40
1500- ≤2500g 49 43 25 35
> 2500g 17 15 10 14
Classification birth weight/GA AIG 98 85 63 88
0,813*PIG 13 11 8 11
GIG 4 3 1 1
Apgar (1st Min.) 0 – 3 16 14 11 15
0,9664-6 41 36 25 35
>7 58 50 36 50
Apgar (5th Min.) 4 – 6 17 15 12 17
0,729
>7 98 85 60 83
*Chi-Square test for Independence using the Monte Carlo permutation method.
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Figure 1: Graphical demonstration of growth of preterm infants. Cascavel, Paraná, Brazil. 
A-Weight, A.1- Weight Z score. B- Height, B.1- Height Z score. C- HC, C.1- HC Z score. (n= 72)
Table 3: Biochemical parameters predictors of metabolic syndrome in preterm infants. Cascavel, Paraná, Brazil, 2017. (n= 72)
Variables Average (DP) Min-Max p value
Glycaemia (mg/l)
Admission 80,4 ± 44,8 20-285
Discharge 82,6 ± 23,8 20-164 0,838
6 months 83,3 ± 12,6 63-132
Triglycerides (mg/dl)
Admission 48,1 ± 31,2a 13-139
Discharge 113,4 ± 33,2b 56-215 <0,0001
6 months 151,1 ± 70,4c 46-338
Cholesterol (mg/dl)
Admission 82,7 ± 28,8a 50-192
Discharge 95,0 ± 39,5b 34-195 <0,0001
6 months 139 ± 29,0c 83-240
Insulin (uUI/mL)
Admission 11,1± 23,2a 0,50-177,3
Discharge 7,3 ± 9,3ab 0,36-45,36 0,024
6 months 4,2 ± 4,3b 0,19-18,7
P-value of ANOVA for repeated measures for each variable. Lowercase letters reflect the statistical differences observed in the LSD-
Fisher follow-up test.
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The growth dynamics of PT consist of maximum 
acceleration between 36 and 40 weeks of post-
conceptional age, presenting the highest catch-up, that is, 
the greatest growth velocity between 24 and 36 months, 
when they reach normal percentiles on the reference 
curves. Extremely low-birth-weight PTs recover even 
more slowly; however, they attain lower-than-expected 
percentiles on the growth curves15. In the present study, 
the mean Z score also showed a reduction between birth 
and the first evaluation, with recovery of the Z score from 
the 2nd evaluation, but remaining lower than expected, 
that is, the gain was less than 0.67 standard deviations. 
For CP, the variation was -0.12±0.11 and 
-0.40±0.17, with a strong decline in the means up to 
the first evaluation. The highest mean was observed in 
the second evaluation, with a significant decrease in the 
third evaluation (p<0.05). Growth velocity acceleration is 
expected with initial CP recovery, followed by height and 
last weight, so that the PT reaches a growth equilibrium and 
reaches, after this recovery, the adequate growth channel, 
indicated by the growth curves as a Z score between the 
Z-2 and the Z-score16. The growth of the PTs evaluated 
had not yet stabilized; therefore, they did not fully present 
the acceleration of growth velocity, especially for the CP, 
which should be the first to enter the appropriate growth 
channel. 
In a study conducted in Australia with extremely 
premature infants and a control group of term new-borns, 
the differences in birth weight score were significantly 
lower at discharge and were progressively reduced up to 
18 years of age17.
The growth of a premature infant should follow that 
of a foetus of the same GI, both in growth rate and body 
composition17. The extrauterine growth retardation, which 
results in a lower than expected growth, in the first weeks 
of life occurs in the first weeks of life, the lower the GI 
and the birth weight, as well as the associated morbidities, 
the greater weight loss in the first days of life and delay in 
recovery due to intercurrent hospitalization.
Longitudinal growth assessment is a fundamental 
reference in the follow-up of children born prematurely 
and is essential to minimize the consequences for their 
development originating in the RCEU13. In this study, 
the deceleration of CP growth in the first and third month 
after hospital discharge with slow recovery until the sixth 
month of CA is a cause for concern. The literature18 points 
out that prematurity and low birth weight are factors that 
exert a strong influence on growth and growth deficits 
in childhood, with repercussions in adult life. Therefore, 
observations indicate that the study sample is vulnerable 
to growth delays and possibly altered development 
throughout childhood. 
Studies on the lipid, glycaemic and insulinemic 
profiles of PT are not common in the literature; therefore, 
there are no standard values for premature children. Thus, 
the study used as a reference data from the American 
Academy of Pediatrics19, which indicate that in healthy 
new-borns it is common to find glycaemia with values 
of 30mg/dl for up to 1–2 hours after birth. Plasma 
 DISCUSSION
concentrations above 125mg/dL are characterized as 
hyperglycaemia; however, other authors20 use 180mg/
dl as a reference. The insulinemic rates were within the 
parameters considered normal for age.
According to the Brazilian Society of Clinical 
Analyses by the recent Brazilian Consensus for the 
regulation of the lipid profile of 201621, cholesterol 
levels ≥170mg/dl and triglycerides ≥75mg/dl fasted and 
≥85 mg/dl without fasting are considered high. Thus, 
the PT of the study sample presented cholesterolaemia 
within normal parameters from birth; however, the 
concentration of triglycerides was higher than expected 
from hospital discharge onward, which reinforces the 
association between prematurity and the development of 
some compromised health conditions in both children and 
adults22. High triglyceride concentrations in PT increase 
the risk of developing cardiovascular diseases in the future; 
therefore, we must invest in actions that promote adequate 
nutrition for these children from birth to minimize the 
risks of future chronic diseases23. Moreover, this evidence 
indicates that during the follow-up of this group in the first 
years of life, the evolution of the lipid profile should be 
followed, since at 2 years of age the child will have the 
cholesterol levels he or she will maintain in the first 10 
years of life24.
 When born prematurely, the PT does not have the 
opportunity to accumulate the requisite energy deposits 
by the end of the gestational period. Therefore, those who 
have experienced intrauterine growth restriction need to 
use endogenous reserves, activating lipid metabolism to 
generate energy and promote gluconeogenesis. The long-
term consequences of these metabolic adaptations will 
lead to an increase in the prevalence of cardiovascular 
diseases, hypertension and DM2 in this group25.
 From the lipid profiles obtained in this study 
and based on evidence from international studies, like 
Adamkin19, Ghaemi et al.22 Ramaraj et al.23, it is identified 
that these PT can be considered as at risk for cardiovascular 
impairment and development of MS throughout their lives.
Recognizing the vulnerability of PT to developing 
MS, it is necessary to take action aimed at reducing 
this risk. One such initiative is to encourage exclusive 
breastfeeding after discharge from the NICU, since this is 
considered a protective factor against the development of 
MS, both in childhood and in adulthood26.
Therefore, the data observed in our study, in 
combination with the literature, evidences that children 
born prematurely are prone to delayed growth and to 
developing cardiovascular changes throughout life.
Close monitoring of the growth and development 
of preterm infants, primarily in their first year of life, may 
contribute to the prevention of future complications. The 
results of anthropometric evaluation during the follow-
up of PT indicate an evolution of growth in relation to 
the measurements themselves. However, their scores 
compared with those of full-term-born infants of the 
same CA followed a downward curve from birth to 
hospital discharge27, which resulted in extrauterine growth 
retardation, indicating slowness in attaining the expected 
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 CONCLUSION
However, because it is a follow-up study, we have 
as a limitation of the work the loss of the participants until 
the final outcome of the evaluation period.
In view of the survival of infants born preterm and 
understanding that this group is vulnerable to develop 
in later stages of their life problems such as CVD, DM2 
and obesity, it is pointed out as contributions to the 
field of public health that one must consider the aspects 
that involve the perinatal period in the prevention of 
future chronic conditions. In order to reduce the risk of 
premature and low birth weight infants being exposed to 
the development of chronic no communicable diseases, 
which increases mortality in adulthood and is extremely 
costly to the public health service.
This study, by describing the evolution of the 
growth associated to the evolution of the metabolic 
profile in the first six months of corrected age, showed 
parameters for age when they reached the sixth month of 
CA.
The lipid profile of PT showed a gradual increase 
in plasma concentrations from birth to 6 months of CA, 
and triglycerides showed high concentrations relative to 
those in the literature. Thus, PTs are part of a population 
at risk for the development of cardiovascular problems 
throughout their lives.
Therefore, during the follow-up of preterm infants 
during hospitalization, as well as throughout their first 
years of life, it is essential to evaluate their glycaemic and 
lipid profile correlating with the evolution of growth in the 
period to promote early interventions that may contribute 
to reduction of damage in adult life, as well as prevent 
the development of chronic conditions such as obesity, 
diabetes mellitus and cardiovascular problems.
that the extrauterine growth retardation is a reality for 
this group and that the lipid profile is altered to the serum 
concentration of triglycerides.
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Resumo
Introdução: Com os avanços nas últimas décadas na medicina materno-fetal e neonatal, observa-se 
maior sobrevida de crianças prematuras com peso de nascimento e idade gestacional progressivamente 
menores, elevando riscos de morbidades futuras. Dentre as quais, alterações do crescimento e no 
metabolismo dessas crianças. 
Objetivo: Analisar a evolução do crescimento e o perfil metabólico de uma coorte de prematuros do 
nascimento aos seis meses de idade corrigida. 
Método: Estudo de descritivo, prospectivo, amostra de 107 mães e 115 recém-nascidos prematuros, 
ao nascimento e 72 lactentes prematuros e 68 mães ao término do seguimento. Crescimento (peso 
corporal, estatura, perímetro cefálico) avaliado em seis momentos. Concentrações plasmáticas de 
colesterol, triglicerídeos, glicose e insulina dos prematuros avaliadas em três períodos, do nascimento 
aos seis meses de Idade Corrigida (IC). Análise da comparação da amostra inicial com amostra que 
finalizou o seguimento mediante testes da família qui quadrado. Para a avaliação do crescimento ao 
longo dos seis meses, a análise ocorreu por meio de delineamento de medidas repetidas.
Resultados: Variáveis sociodemográficas e perfil bioquímico materno sem diferenças estatísticas entre 
mães da amostra inicial e aquelas que finalizaram o seguimento. Crescimento linear dos prema 
turos da alta aos seis meses de IC, contudo sem recuperação do crescimento. Concentrações plasmáticas 
de triglicerídeos (nascimento=48,1; 6 meses=151,1) e colesterol (nascimento=82,7; 6 meses=139,9), 
aumentaram no decorrer das avaliações. Glicemia permaneceu estável (nascimento=80,4; 6 
meses=83,3) e insulina reduziu de 11,0, para 4,2.
Conclusão: O crescimento dos recém-nascidos prematuros, apesar de linear, inferior ao esperado 
para idade. Perfil lipídico apresentou curva ascendente desde o nascimento. 
Palavras-chave: recém-nascido prematuro, crescimento, lipídeos, glicose, insulina
